Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.960
-0.010 (-0.51%)
Nov 13, 2026, 4:00 PM EST - Market closed

PACB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
161.39160.01154.01200.52128.3130.51
Revenue Growth
4.41%3.89%-23.19%56.29%-1.69%65.43%
Cost of Revenue
116.74105.15106.34142.3274.8371.35
Gross Profit
44.6654.8547.6758.253.4759.17
Selling, General & Admin
128.81137.69175.02169.82160.85124.12
Research & Development
85.7395.21134.92187.17193112.9
Amortization of Goodwill & Intangibles
363.36369.4427.48.140.730.31
Other Operating Expenses
4.184.1813.443.71-
Operating Expenses
582.09606.51338.34368.56358.29237.33
Operating Income
-537.43-551.66-290.66-310.37-304.82-178.16
Interest Expense
-7.65-6.95-13.41-14.34-14.69-12.53
Other Non Operating Income (Expenses)
11.4310.3910.7419.847.394.1
EBT Excluding Unusual Items
-533.65-548.22-293.34-304.86-312.12-186.59
Merger & Restructuring Charges
387.2-5.9--9.04--83.13
Impairment of Goodwill
---144.5---
Gain (Loss) on Sale of Investments
1.034.3713.0412.840.24-4.01
Asset Writedown
-15-15-40---
Other Unusual Items
-18.7155.26-17.09-2.38-1.14
Pretax Income
-130.52-546.06-309.54-318.16-314.25-274.87
Income Tax Expense
0.710.320.32-11.42--93.65
Net Income
-131.23-546.38-309.85-306.74-314.25-181.22
Net Income to Common
-131.23-546.38-309.85-306.74-314.25-181.22
Net Income Growth
------
Shares Outstanding (Basic)
307300274254225204
Shares Outstanding (Diluted)
307300274254225204
Shares Change
4.13%9.28%8.22%12.95%10.00%16.67%
EPS (Basic)
-0.43-1.82-1.13-1.21-1.40-0.89
EPS (Diluted)
-0.43-1.82-1.13-1.21-1.40-0.89
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-143.4-113.92-212.25-268.02-279.96-117.11
Free Cash Flow Per Share
-0.47-0.38-0.77-1.06-1.25-0.57
Gross Margin
27.67%34.28%30.95%29.02%41.68%45.33%
Operating Margin
-332.99%-344.78%-188.73%-154.78%-237.58%-136.51%
Profit Margin
-81.31%-341.47%-201.18%-152.97%-244.93%-138.85%
Free Cash Flow Margin
-88.85%-71.20%-137.81%-133.66%-218.20%-89.73%
EBITDA
-163.3-169.23-249.48-290.64-294.43-170.58
EBITDA Margin
-101.18%-105.76%-161.98%-144.94%-229.47%-130.70%
D&A For EBITDA
374.13382.4441.1919.7210.397.58
EBIT
-537.43-551.66-290.66-310.37-304.82-178.16
EBIT Margin
---188.73%-154.78%-237.58%-136.51%
Revenue as Reported
161.39160.01154.01200.52128.3130.51
SEC Filings: 10-K · 10-Q